PharmaTimes | Lynne Taylor
Germany has come top of a new
international league table in terms of access to medicines for patient
organisations, with Italy and France in joint second place and the UK coming
fourth.
The survey, conducted by
PatientView, asked patient groups in 12 countries or regions about their
ability to gain access to medicines, for example, by influencing the health
technology assessment (HTA) process in their country. The fifth-best access,
after that in the UK, was found in the Nordic countries, followed by Canada in
sixth place.
The US and central and
south America are next, in joint seventh place, followed by the Netherlands and
Australasia, joint ninth, then Spain in eleventh place and finally, placed
twelfth, with the worst access, is Eastern Europe.